http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100090690-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56 |
filingDate | 2008-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_949cd3039c21ad9896145f1e067bdaa5 |
publicationDate | 2010-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20100090690-A |
titleOfInvention | Combination of angiogenesis inhibitors and anti-tumoral platinum complexes |
abstract | The subject of this invention is finding out the pharmaceutical composition which shows the outstanding anti-tumor effect, and the method of treating cancer. 4- (3-chloro-4- (cyclopropylaminocarbonyl) aminophenoxy) -7-methoxy-6-quinolinecarboxamide and similar compounds thereof, or pharmacologically acceptable salts thereof, or solvates thereof Can exhibit excellent anti-tumor effect by use with anti-tumoral platinum complex. |
priorityDate | 2007-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 198.